Neuroimaging study of idiopathic generalized epilepsy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033957

Enrollment

Unknown

Registered

2020-06-18

Start date

2021-05-01

Completion date

Unknown

Last updated

2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

IGE group:Nil

Healthy group:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. IGE patients diagnosed with IGE based on the clinical and seizure semiology information consistent with the 2017 International League Against Epilepsy guidelines by two qualified neurologists. 2. Healthy individuals without neuropsychiatric disease, drug abuse or sleep disorder. 3. All subjects give informed consent.

Exclusion criteria

Exclusion criteria: 1. A conventional MRI brain examination shows any lesion. 2. Individuals who cannot complete the MRI scans. 3. Individuals who suffer neuropsychiatric comorbidity, drug abuse, alcohol addition or sleep disorders.

Design outcomes

Primary

Measure	Time frame
MRI data;primary clinical semiology;	—

Secondary

Measure	Time frame
age;course of disease;sex;	—

Countries

China

Contacts

Public ContactYang Tianhua

West China Hospital of Sichuan University

yangtianhua79@yahoo.com.cn+86 18980606300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026